OvaScience

MLND NASDAQ
16.41
-0.27
-1.62%
After Hours: 16.41 0 0.00% 16:34 05/17 EDT
Open
16.49
Prev Close
16.68
High
16.50
Low
15.93
Volume
13.29K
Avg Vol (3M)
33.08K
52 Week High
17.34
52 Week Low
6.77
% Turnover
0.10%
Market Cap
219.20M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Company Profile

Millendo Therapeutics, Inc., formerly OvaScience, Inc. is a late-stage biopharmaceutical company. The Company is focused on developing novel treatments for orphan endocrine diseases. The Company is focused on advancing two product candidates to treat three indications. Its advanced product candidate, livoletide (AZP-531), is a potential treatment for Prader-Willi syndrome (PWS), which is a rare and complex genetic endocrine disease characterized by hyperphagia, or insatiable hunger. It is also developing nevanimibe (ATR-101) with a primary focus on treating patients with classic congenital adrenal hyperplasia (CAH), which is a rare, monogenic adrenal disease that requires lifelong treatment with exogenous cortisol.
MORE >

Recently

Name
Price
%Change